
SOTS 2nd Hour: More S&P Record Highs, Netflix Breakdown, LIVE: Deputy Treasury Secretary 7/18/25
Squawk on the Street
00:00
Market Struggles and Controversies in Gene Therapy Trials
This chapter examines the recent downturn in the financial sector, spotlighting the struggles of regional banks and Charles Schwab amidst disappointing earnings reports. It also delves into Sarepta's troubling situation following a third death linked to its gene therapy, raising critical questions about the company's transparency and management credibility.
Transcript
Play full episode